Drug Trial Radar · NCT06635057
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan
Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
166
Actual
Start
Oct 11, 2024
Primary completion
Apr 15, 2026
Study completion Apr 15, 2026
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Oct 10, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of the study is to investigate whether tirzepatide can be effectively started before Ramadan and used per label in participants with Type 2 Diabetes during the fasting month.
Conditions
- Type 2 Diabetes
Interventions
TirzepatideDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in Hemoglobin A1c (HbA1c)Time frame: Baseline (20 to 8 weeks Before Ramadan), Week 4-8 from Start of Ramadan (SoR)
Locations
29 sites in 2 countries. Site status is shown where the registry gives one.
Al Moosa Specialist Hospital
Al Ahasa, Saudi Arabia
National Guard Hospital-King Abdulaziz Medical City
Alahsa, Saudi Arabia
King Abdulaziz Medical City-Jeddah
Jeddah, Saudi Arabia
King Fahad Armed Forces Hospital Jeddah
Jeddah, Saudi Arabia
King Faisal Specialist Hospital & Research Center
Jeddah, Saudi Arabia
Saudi Airlines Medical services
Jeddah, Saudi Arabia
King Faisal Specialist Hospital and Research Center Madina
Madinah, Saudi Arabia
King Saud University
Riyadh, Saudi Arabia
Osepdale Fatebenefratelli e Oftalmico
Riyadh, Saudi Arabia
Al Dallah Hospital
Riyadh, Saudi Arabia
Sulaiman Habib Olaya
Riyadh, Saudi Arabia
Specialized Medical Center Hospital
Riyadh, Saudi Arabia
Dallah Namar Hospital
Riyadh, Saudi Arabia
Dr. Sulaiman Al Habib Hospital As Suwaidi
Riyadh, Saudi Arabia
Dr. Sulaiman Al Habib Medical Complex Arrayan Saudi Arabia
Riyadh, Saudi Arabia
Lifecare Hospital
Abu Dhabi, United Arab Emirates
Tawam Hospital
Abu Dhabi, United Arab Emirates
Imperial College London Diabetes Center
Abu Dhabi, United Arab Emirates
NMC Abu Dhabi
Abu Dhabi, United Arab Emirates
Rashid Centre for Diabetes and Research
Ajman, United Arab Emirates
Thumbay University Hospital
Ajman, United Arab Emirates
Emirates Hospital Dubai
Dubai, United Arab Emirates
Aster Clinics
Dubai, United Arab Emirates
Dubai Diabetes Center
Dubai, United Arab Emirates
Dubai Hospital
Dubai, United Arab Emirates
Medcare Hospital
Dubai, United Arab Emirates
Mediclinic City Hospital
Dubai, United Arab Emirates
Rashid Hospital.
Dubai, United Arab Emirates
Medcare Hospital
Sharjah city, United Arab Emirates
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.